272 related articles for article (PubMed ID: 32592163)
1. 'Primed' Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients.
Raza SS; Seth P; Khan MA
Stem Cell Rev Rep; 2021 Feb; 17(1):153-162. PubMed ID: 32592163
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
[TBL] [Abstract][Full Text] [Related]
3. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
Jamshidi E; Babajani A; Soltani P; Niknejad H
Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
[TBL] [Abstract][Full Text] [Related]
4. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
5. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
Yadav P; Vats R; Bano A; Bhardwaj R
Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
Sadeghi S; Soudi S; Shafiee A; Hashemi SM
Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
[TBL] [Abstract][Full Text] [Related]
8. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
Golchin A; Seyedjafari E; Ardeshirylajimi A
Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
Xiong J; Bao L; Qi H; Feng Z; Shi Y
Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
[TBL] [Abstract][Full Text] [Related]
11. The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19.
Saburi E; Abazari MF; Hassannia H; Mansour RN; Eshaghi-Gorji R; Gheibi M; Rahmati M; Enderami SE
Gene; 2021 Apr; 777():145471. PubMed ID: 33549712
[TBL] [Abstract][Full Text] [Related]
12. Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.
Jeyaraman M; John A; Koshy S; Ranjan R; Anudeep TC; Jain R; Swati K; Jha NK; Sharma A; Kesari KK; Prakash A; Nand P; Jha SK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166014. PubMed ID: 33232817
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell therapy for severe COVID-19.
Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS
Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19.
Paris GC; Azevedo AA; Ferreira AL; Azevedo YMA; Rainho MA; Oliveira GP; Silva KR; Cortez EAC; Stumbo AC; Carvalho SN; de Carvalho L; Thole AA
Life Sci; 2021 Aug; 278():119510. PubMed ID: 33865879
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
Tufan AC
Curr Stem Cell Res Ther; 2021; 16(4):465-480. PubMed ID: 33238848
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
[TBL] [Abstract][Full Text] [Related]
19. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
20. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]